Forge Therapeutics To Present At The BIOCOM Global Life Science Partnering Conference
SAN DIEGO, Feb. 18, 2016 /PRNewswire/ -- Forge Therapeutics, Inc., a biotechnology company discovering innovative therapeutics using a breakthrough drug discovery platform targeting metalloproteins, announced today that Zachary Zimmerman, Ph.D., Chief Executive Officer, will present a corporate overview at the BIOCOM Life Science Partnering Conference being held at the Lodge at Torrey Pines, San Diego, CA on February 24th & 25th, 2016.
"It is an honor to be selected to present at this prestigious partnering conference that attracts life science executives from around the globe to visit San Diego and become inspired by our vibrant biotech ecosystem," said Zachary A. Zimmerman, Ph.D., CEO of Forge Therapeutics. "This is a great opportunity to showcase the Forge technology and our leading efforts in Gram-negative bacteria where we have developed the first non-hydroxamate inhibitor of LpxC that is potent in cells, including multi-drug resistant superbugs, and efficacious in vivo."
The presentation will include an overview of Forge's metalloprotein technology platform, lead therapeutic programs in Gram negative bacteria, epigenetics, and cancer immunity, as well as financing and partnering strategies.
Details of Forge's presentation:
BIOCOM Life Science Partnering Conference
Wednesday, February 24th
10:40 AM PST
Alfred Mitchell Room
About Forge Therapeutics, Inc.
Forge Therapeutics, Inc. ("Forge") is a biotechnology start-up that leverages its novel chemistry platform to develop small molecule inhibitors to target metalloproteins. Metalloproteins are proteins that require metal ions for their biological function and make up over 1/3 of the proteins in the human body. Forge uses a proprietary approach comprised of molecular modeling for rational drug design along with fundamental knowledge and expertise in bioinorganic chemistry to target metalloproteins. The name Forge Therapeutics comes from two definitions for forge: to manipulate (inhibit) a metal object (metalloprotein) and to move forward steadily with a purpose (the Forge team). Forge Therapeutics, Inc., maintains its headquarters in San Diego, California. To learn more please visit www.ForgeTherapeutics.com
About BIOCOM Global Life Science Partnering Conference
In its 6th Year, the BIOCOM Global Life Science Partnering Conference is an exclusive partnering forum that provides senior executives, bankers, venture capitalists, and business development professionals from the leading pharmaceutical and biotech companies to network and do business with one another from around the globe. To learn more please visit http://biocomglobalpartnering.org/
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/forge-therapeutics-to-present-at-the-biocom-global-life-science-partnering-conference-300221897.html
SOURCE Forge Therapeutics, Inc.